April 16, 2022
Accelus and CHP Merger Corp. Mutually Agree To Terminate Business Combination
PALM BEACH GARDENS, Fla. and SUMMIT, N.J., April 15, 2022 (GLOBE NEWSWIRE) — Integrity Implants Inc. d/b/a Accelus (“Accelus”), a…
Pharmaceuticals, Biotechnology and Life Sciences
PALM BEACH GARDENS, Fla. and SUMMIT, N.J., April 15, 2022 (GLOBE NEWSWIRE) — Integrity Implants Inc. d/b/a Accelus (“Accelus”), a…
Company voluntarily withdraws UKONIQ® from sale for approved indications of relapsed/refractory MZL and FL Company to host conference call, Monday,…
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced…
PASADENA, CA, April 14, 2022 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing…
Monthly information regarding the total number of voting rights and total number of shares of the Company as…
SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field…
CAMBRIDGE, Mass., April 14, 2022 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today…
Scientific Advisory Board strengthens LianBio’s mission of bringing novel therapeutics to Greater China and AsiaSHANGHAI, China and PRINCETON, N.J., April…
IRVINE, Calif., April 14, 2022 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company…
UNIONDALE, N.Y., April 14, 2022 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (NASDAQ:ANGN), a biopharmaceutical company focused on the discovery, development,…